Form 483

Newton Laboratories, Inc. Form 483, 2026-03-26

FDA issued a Form 483 to Newton Laboratories, Inc. on 2026-03-26 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Newton Laboratories, Inc. · Conyers, United States · Issued March 26, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Mar 2026
21 CFR 211.166(a)

Written program not followed

Cited by Martin M Kimani, John D Mcintosh

26 Mar 2026
21 CFR 211.198(a)

Quality Control Review

Cited by Martin M Kimani, John D Mcintosh

26 Mar 2026
21 CFR 211.94(b)

Protection from external factors

Cited by Martin M Kimani, John D Mcintosh

Inspected site

NLNewton Laboratories, Inc.Conyers, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.94(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere